409 related articles for article (PubMed ID: 30967621)
1. B cell checkpoints in autoimmune rheumatic diseases.
Rubin SJS; Bloom MS; Robinson WH
Nat Rev Rheumatol; 2019 May; 15(5):303-315. PubMed ID: 30967621
[TBL] [Abstract][Full Text] [Related]
2. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.
Kattah NH; Kattah MG; Utz PJ
Immunol Rev; 2010 Jan; 233(1):126-45. PubMed ID: 20192997
[TBL] [Abstract][Full Text] [Related]
3. Regulation of autoreactive B cells: checkpoints and activation.
Ding C; Yan J
Arch Immunol Ther Exp (Warsz); 2007; 55(2):83-9. PubMed ID: 17347802
[TBL] [Abstract][Full Text] [Related]
4. Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD).
Pouw JN; Leijten EFA; van Laar JM; Boes M
Clin Exp Immunol; 2021 Feb; 203(2):160-173. PubMed ID: 33090496
[TBL] [Abstract][Full Text] [Related]
5. Making and breaking tolerance.
Ohashi PS; DeFranco AL
Curr Opin Immunol; 2002 Dec; 14(6):744-59. PubMed ID: 12413525
[TBL] [Abstract][Full Text] [Related]
6. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
Mackay F; Sierro F; Grey ST; Gordon TP
Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
[TBL] [Abstract][Full Text] [Related]
7. B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells.
Bonasia CG; Abdulahad WH; Rutgers A; Heeringa P; Bos NA
Cells; 2021 May; 10(5):. PubMed ID: 34068035
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors and their role in the development of autoimmune diseases.
Toubi E; Shoenfeld Y
Autoimmunity; 2004 May; 37(3):183-8. PubMed ID: 15497450
[TBL] [Abstract][Full Text] [Related]
9. The role of B cell antigen presentation in the initiation of CD4+ T cell response.
Hua Z; Hou B
Immunol Rev; 2020 Jul; 296(1):24-35. PubMed ID: 32304104
[TBL] [Abstract][Full Text] [Related]
10. Signaling mechanisms regulating B-lymphocyte activation and tolerance.
Hobeika E; Nielsen PJ; Medgyesi D
J Mol Med (Berl); 2015 Feb; 93(2):143-58. PubMed ID: 25627575
[TBL] [Abstract][Full Text] [Related]
11. FcγRIIB and autoimmunity.
Espéli M; Smith KG; Clatworthy MR
Immunol Rev; 2016 Jan; 269(1):194-211. PubMed ID: 26683154
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.
Ceeraz S; Nowak EC; Burns CM; Noelle RJ
Arthritis Res Ther; 2014; 16(5):469. PubMed ID: 25606596
[TBL] [Abstract][Full Text] [Related]
13. [Regulatory T cells and rheumatic diseases].
Humrich JY; Kamradt T; Riemekasten G
Z Rheumatol; 2015 Feb; 74(1):26-32. PubMed ID: 25676125
[TBL] [Abstract][Full Text] [Related]
14. Functional interplay between intrinsic B and T cell defects leads to amplification of autoimmune disease in New Zealand black chromosome 1 congenic mice.
Cheung YH; Chang NH; Cai YC; Bonventi G; MacLeod R; Wither JE
J Immunol; 2005 Dec; 175(12):8154-64. PubMed ID: 16339554
[TBL] [Abstract][Full Text] [Related]
15. B cell immunobiology in disease: evolving concepts from the clinic.
Martin F; Chan AC
Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256
[TBL] [Abstract][Full Text] [Related]
16. The Contribution of B Cells in Autoimmune Liver Diseases.
Taylor SA; Assis DN; Mack CL
Semin Liver Dis; 2019 Nov; 39(4):422-431. PubMed ID: 31226726
[TBL] [Abstract][Full Text] [Related]
17. B cells participate in tolerance and autoimmunity through cytokine production.
Luu VP; Vazquez MI; Zlotnik A
Autoimmunity; 2014 Feb; 47(1):1-12. PubMed ID: 24245950
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease.
Horst AK; Kumashie KG; Neumann K; Diehl L; Tiegs G
Cell Mol Immunol; 2021 Jan; 18(1):92-111. PubMed ID: 33110250
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of B cells for rheumatic autoimmune diseases.
Engel P; Gómez-Puerta JA; Ramos-Casals M; Lozano F; Bosch X
Pharmacol Rev; 2011 Mar; 63(1):127-56. PubMed ID: 21245206
[TBL] [Abstract][Full Text] [Related]
20. Rheumatic autoimmune diseases: proposed elimination of autoreactive B-cells with magnetic nanoparticle-linked antigens.
Bollmann FM
Med Hypotheses; 2012 Apr; 78(4):479-81. PubMed ID: 22285628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
